Navigation Links
Conduit TCP Granules Bone Graft

ProductsConduit TCP Granules Bone Graft
Company DePuy Orthopaedics, Inc.
Item Conduit TCP Granules Bone Graft
Features Composed of the constituents that comprise 70% of the mineral phase of bone. No inflammatory response or reported case of rejection. Synthetic material eliminates risk of viral transmission. Interconnected multidirectional pores that mimic the structure of human cancellous bone. Porosity. Pore size average of 1-600m optimizes cellular in-growth and attachment and strongly encourages integration inside bone tissue. Connected porosity (inter-granular and intra-granular) and allows for vascular development. Faster resorption than Hydroxyapatite implants. Osseointegrated due to chemical composition and pore structure similar to human bone.
Description Conduit TCP is a synthetic porous ceramic graft material composed of Tricalcium Phosphate, which is similar to the mineral phase that comprises 70% of human bone. TCP is an osteoconductive material that provides a scaffold that allows the attachment of bone forming cells and allows for the development of vascular networks within granules as well as between each granule. Conduit TCP strikes the perfect balance between structural integrity and porosity, which better mimics that of a patient's own bone as compared to other synthetic graft materials. Conduit TCP is resorbed through cell mediated events that are involved in the normal remodeling cycle of bone.
Info DePuy Orthopaedics, Inc.
Customer Service: (800) 366-8143
Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

Related medicine products :

1. Chronos Granules Bone Graft Substitute
2. TruGraft Synthetic Bone Graft Substitute Granules
3. Grafton Trial Frame
4. Blair-Brown Skin Graft Knife
5. Braithwaite Skin Graft Knife
6. Watson Skin Graft Knife
7. Duragen Dural Graft Matrix
8. I/C Graft Chamber, GDS010
9. I/C Graft Chamber, GDS015
10. I/C Graft Chambers, GDS005
11. Grafton DBM Crunch
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The Osom® Bvblue Test detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with Bacterial Vaginosis including Gardnerella, Bacteroides, Prevote...
Nitinol Tipless Stone Basket...
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
Medicine Products:
(Date:12/6/2016)... ... December 06, 2016 , ... An ... much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a unique ... most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day water ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... Keeping Gift ... people choose gifts that are safe and age-appropriate for their recipients. This is the ... to reflect on the safety of items that would make good gifts for children. ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain . Leading ... of their EHS regulatory obligations and rapidly collect, share, archive, and export audit ...
(Date:12/6/2016)... ... 06, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has announced the addition of a Public Sector ... training to public sector employees. , “The primary goal of the Public Sector ...
(Date:12/6/2016)... ... December 06, 2016 , ... U.S. Security Associates (USA) was ... for their industry leading training methods that engage their associates and link their ... global elite in employer-sponsored training and development programs. , “The 2017 Training Top ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Several leading Alzheimer,s disease experts will participate in ... 11 a.m. EST on December 6 in advance of ... Alzheimer,s Disease (CTAD). The program will include discussions on ... targets that address deficient glucose metabolism observed in Alzheimer,s ... another therapy targeting the amyloid hypothesis, now more than ...
(Date:12/5/2016)... 5, 2016 Research and Markets has ... (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User ... to 2021" report to their offering. ... , , ... in 2021 from USD 574.8 Million in 2016, growing at a ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 According to ... Product Type and by Application - Global Opportunity Analysis and Industry Forecast, 2014 ... and is expected to reach $5,255 million by 2022, growing at a CAGR ... 2015 with more than four-fifths share. Continue Reading ... ...
Breaking Medicine Technology: